InsidersTradesSigma
Total declarations
Company
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by Leavitt Chase C.. Director active across 1 companies, notably Oncternal Therapeutics, Inc.. Cumulatively, 6 reports have been logged. Total volume traded: €40k. The latest transaction was filed on 27 January 2022 — Acquisition. Regulator: SEC (Form 4). All data is openly available.
Declarations6 total
€13,4578,500 shares@ €1.583166.7% of flow
Common Stock
SEC:0001209191-22-005558·
Ideal exit: 24 Oct 2022 (T+270)
€13,4578,500 shares@ €1.583133.4% of flow
Common Stock
SEC:0001209191-22-005558:0·
Ideal exit: 24 Oct 2022 (T+270)
029,867 shares0
Common Stock
SEC:0001209191-22-001973·
029,867 shares0
Common Stock
SEC:0001209191-22-001973:0·
€6,7161,500 shares@ €4.477333.3% of flow
Common Stock
SEC:0001209191-21-040701·
Ideal exit: 8 Mar 2022 (T+270)
€6,7161,500 shares@ €4.477316.6% of flow
Common Stock
SEC:0001209191-21-040701:0·
Ideal exit: 8 Mar 2022 (T+270)
6 of 6 declarations
About Leavitt Chase C.
Chase C. Leavitt is a director at Oncternal Therapeutics, Inc.
